Overview

Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis

Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
To determine the utility of serial cardiac magnetic resonance (CMR) imaging for guidance of therapy management in patients treated with anakinra due to recurrent pericarditis (RP), compared with c-reactive protein (CRP) assay alone.
Phase:
N/A
Details
Lead Sponsor:
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Treatments:
Interleukin 1 Receptor Antagonist Protein